These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32282987)

  • 21. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
    Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM
    J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current challenges in the management of heart failure.
    Komajda M
    Circ J; 2015; 79(5):948-53. PubMed ID: 25877621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-Analysis on Drug and Device Therapy of New York Heart Association Functional Class IV Heart Failure With Reduced Ejection Fraction.
    Batchelor RJ; Nan Tie E; Romero L; Hopper I; Kaye DM
    Am J Cardiol; 2023 Feb; 188():52-60. PubMed ID: 36473305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decade in review--heart failure: 10 Years of progress in HF research--what have we learned?
    Krum H
    Nat Rev Cardiol; 2014 Nov; 11(11):631-3. PubMed ID: 25178503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological therapy of heart failure with reduced ejection fraction].
    Wieser M; Rhyner D; Martinelli M; Suter T; Schnegg B; Bösch C; Wigger O; Dobner S; Hunziker L
    Ther Umsch; 2018 Sep; 75(3):180-186. PubMed ID: 30145973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mineralocorticoid Receptor Antagonist Use in Heart Failure With Reduced Ejection Fraction and End-Stage Renal Disease Patients on Dialysis: A Literature Review.
    Bhinder J; Patibandla S; Gupta CA; Levine A; Gass AL; Lanier GM
    Cardiol Rev; 2020; 28(3):107-115. PubMed ID: 31985521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.
    Vaduganathan M; Fonarow GC; Greene SJ; DeVore AD; Kavati A; Sikirica S; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J
    JACC Heart Fail; 2020 Jun; 8(6):469-480. PubMed ID: 32387066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews.
    Al-Gobari M; Al-Aqeel S; Gueyffier F; Burnand B
    BMJ Open; 2018 Jul; 8(7):e021108. PubMed ID: 30056380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
    Sionis A; ; Sionis Green A; Manito Lorite N; Bueno H; Coca Payeras A; Díaz Molina B; González Juanatey JR; Ruilope Urioste LM; Zamorano Gómez JL; ; Almenar Bonet L; Ariza Solé A; Bover Freire R; Lambert Rodríguez JL; López de Sá E; López Fernández S; Martín Asenjo R; Mirabet Pérez S; Pascual Figal D; Segovia Cubero J; Varela Román A; ; San Román Calvar JA; Alfonso Manterola F; Arribas Ynsaurriaga F; Evangelista Masip A; Ferreira González I; Jiménez Navarro M; Marin Ortuño F; Pérez de Isla L; Rodríguez Padial L; Sánchez Fernández PL; Sionis Green A; Vázquez García R
    Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1119-1125. PubMed ID: 27894486
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
    Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
    Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of ACCF/AHA Stage C heart failure.
    Adigopula S; Vivo RP; DePasquale EC; Nsair A; Deng MC
    Cardiol Clin; 2014 Feb; 32(1):73-93, viii. PubMed ID: 24286580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator.
    Packer M
    Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e007430. PubMed ID: 31159583
    [No Abstract]   [Full Text] [Related]  

  • 33. Guideline-based audit of the hospital management of heart failure with reduced ejection fraction.
    Drak D; Fulcher J; Kilian J; Chong JJH; Grover R; Sindone AP; Adams M; Lattimore JD; Keech AC
    Intern Med J; 2023 Sep; 53(9):1595-1601. PubMed ID: 35666643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden cardiac death in heart failure.
    Klein L; Hsia H
    Cardiol Clin; 2014 Feb; 32(1):135-44, ix. PubMed ID: 24286584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012.
    Thorvaldsen T; Benson L; Dahlström U; Edner M; Lund LH
    Eur J Heart Fail; 2016 May; 18(5):503-11. PubMed ID: 26869252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug treatment for chronic heart failure with reduced ejection fraction].
    Rickenbacher P
    Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry.
    Chang HY; Wang CC; Wei J; Chang CY; Chuang YC; Huang CL; Chong E; Lin JL; Mar GY; Chan KC; Kuo JY; Wang JH; Chen ZC; Tseng WK; Cherng WJ; Yin WH
    J Chin Med Assoc; 2017 Dec; 80(12):750-757. PubMed ID: 29033112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
    Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
    Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.